# Reviva Pharmaceuticals Holdings, Inc.: Form 8-K, filed Jun 6, 2025

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: 8-K
- Filed: 2025-06-06
- Accepted by EDGAR: Jun 6, 2025, 16:06 ET
- Period: 2025-06-03
- Accession: 0001437749-25-019716
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774925019716/rvph20250605_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774925019716/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774925019716/rvph20250605_8k.htm

Filed Jun 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-019716. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.